EN
In tumours of the ovaries, the uterus and the external genitalia, almost everything turns on how completely the operation is carried out and how precisely the drug therapy is matched to it. This is a field where the decision is made not by one surgeon but by a team. Univ.-Prof. Dr med. Sven Mahner heads a clinic in Munich organised in exactly that way.
Who he is and where he practises
Sven Mahner is a specialist in gynaecology and obstetrics and a university professor. Since 2015 he has held the chair of gynaecology and obstetrics at Ludwig Maximilian University of Munich and is director of the clinic and outpatient department for women’s medicine and obstetrics at the LMU University Hospital. The clinic works on two sites — in the city centre and on the Großhadern campus.
He studied medicine in Heidelberg and did part of his training in Boston, New York and Zurich. He qualified at the University Medical Centre Hamburg-Eppendorf, where he later served as acting director of the clinic, before moving to Munich. He is the author or co-author of more than five hundred scientific publications, mostly in gynaecological oncology.
The clinic is part of the LMU university cancer centre — one of the top-level centres selected and funded by the German Cancer Aid (Deutsche Krebshilfe). In practice that means every difficult case goes through a tumour board: surgeon, medical oncologist, radiation oncologist, radiologist and pathologist discuss the approach together.
What he does specifically
His main field is gynaecological oncology, with a particular focus on ovarian and vulvar cancer: the surgery, the choice of drug therapy, and research into why these tumours behave as they do.
In ovarian cancer the key task of the operation is to remove the tumour tissue as completely as possible; it is a major procedure, and its result largely determines everything that follows. Then the drug side comes in: chemotherapy and medicines that act on the molecular features of the particular tumour — which is why clinics like this almost always examine its molecular profile, not just the histology.
Clinical trials are a distinct part of the clinic’s work. For a patient that can sometimes mean access to a treatment regimen that has not yet become routine practice; taking part is always voluntary and is discussed separately. Besides oncology, the clinic runs obstetrics, including pregnancies with risk factors.
How we arrange an appointment
We translate your discharge letters, histology reports and images and send them to the clinic. In return you learn what examinations will be needed on site, how long reviewing the case will take and what it will cost. The clinic invoices you directly. An interpreter is present at the appointment and at the tumour board.
This material is for information only and does not replace a consultation with a doctor. Whether treatment is possible, what it will involve and what it will achieve can be determined only after an examination at the clinic in person.